ReviewClinical Medicine Insights. Oncology2018

Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review.

William Paul Skelton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.